Search

Search Results

• 

  New approved drugs for psoriatic arthritis

  F.M. Perrotta, E. Lubrano

  57-64

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.873

  3480

  PDF: 2379
• 

  Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center

  S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri

  158-165

  19-07-2012

  https://doi.org/10.4081/reumatismo.2012.158

  1192

  PDF: 933
• 

  Far infrared emitting plaster in knee osteoarthritis: a single blinded, randomised clinical trial

  GL. Bagnato, G. Miceli, M. Atteritano, N. Marino, GF. Bagnato

  388-394

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.388

  5488

  PDF: 2948
• 

  Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases

  L. Degli Esposti, L. Sinigaglia, M. Rossini, S. Adami, C. Cagnoni, C. Magliaro, C. Veronesi, S. Buda, S. Minisola

  18-26

  16-03-2012

  https://doi.org/10.4081/reumatismo.2012.18

  2126

  PDF: 1029
• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.682

  3003

  PDF: 1466
• 

  The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

  M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia

  188-194

  31-12-2016

  https://doi.org/10.4081/reumatismo.2016.903

  2244

  PDF: 1065
• 

  A case of mandible Paget’s disease of the bone treated with intravenous neridronate

  A. Fassio, L. Idolazzi, M. Rossini, O. Viapiana, D. Gatti

  154-158

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.917

  2445

  PDF: 1171
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.922

  5174

  PDF: 3333
• 

  Manual therapy and therapeutic exercise in the treatment of osteoarthritis of the hip: a systematic review

  A. Romeo, S. Parazza, M. Boschi, T. Nava, C. Vanti

  63-74

  27-05-2013

  https://doi.org/10.4081/reumatismo.2013.63

  7908

  PDF: 4144
• 

  Bone mineral density in women on long-term mud-bath therapy in a Salus per Aquam (SPA) environment

  A. Loi, S. Lisci, A. Denotti, A. Cauli

  121-125

  24-07-2013

  https://doi.org/10.4081/reumatismo.2013.121

  3138

  PDF: 1137
• 

  Short story of antirheumatic therapy.VIII. The immunodepressants

  G. Pasero, P. Marson

  44-54

  19-03-2012

  https://doi.org/10.4081/reumatismo.2012.44

  1771

  PDF: 1551
• 

  Three-dimensional morphological condylar and mandibular changes in a patient with juvenile idiopathic arthritis: interdisciplinary treatment

  G. Farronato, C. Bellintani, U. Garagiola, P. Cressoni, P. Sarzi Puttini, F. Atzeni, M. Cazzola

  254-257

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.725

  2847

  PDF: 1439
• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.143

  7606

  PDF: 2805
• 

  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

  S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

  78-84

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1011

  2933

  PDF: 1502
• 

  Possible relationship between certolizumab pegol and arrhythmias: report of two cases

  R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini

  104-108

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.869

  1953

  PDF: 1119
• 

  Work-related carpal tunnel syndrome treatment: a cross-sectional study among 106 patients

  M. Aouatef, B. Asma, H. Hajer, A. Charfeddine, B. Lamia, K. Taoufik

  59-64

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.978

  2982

  PDF: 1365
• 

  Update on treatment of polymyalgia rheumatica

  D. Camellino, C. Dejaco

  59-66

  27-03-2018

  https://doi.org/10.4081/reumatismo.2018.1062

  6280

  PDF: 3553
• 

  Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios

  O. Di Munno, A. Delle Sedie

  67-79

  https://doi.org/10.4081/reumatismo.2011.67

  1805

  PDF: 1078
• 

  Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

  A. Bortoluzzi, M. Padovan, I. Farina, E. Galuppi, F. De Leonardis, M. Govoni

  350-359

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.350

  3379

  PDF: 2793
• 

  Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients

  S. Soldano, P. Montagna, R. Brizzolara, C. Ferrone, A. Parodio, A. Sulli, B. Seriolo, B. Villaggio, M. Cutolo

  326-334

  11-12-2012

  https://doi.org/10.4081/reumatismo.2012.326

  1928

  PDF: 1006
• 

  Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

  F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro

  208-214

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.756

  2969

  PDF: 1629
• 

  IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

  S. Iervolino, M. Lofrano, M.N.D. Di Minno, F. Foglia, R. Scarpa, R. Peluso

  40-43

  19-03-2012

  https://doi.org/10.4081/reumatismo.2012.40

  1139

  PDF: 1734
• 

  Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs

  E. Lubrano, R. Scarpa

  107-112

  05-06-2012

  https://doi.org/10.4081/reumatismo.2012.107

  1586

  PDF: 1410
• 

  Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

  B.D. Nielsen, B. Dasgupta

  1-9

  27-03-2018

  https://doi.org/10.4081/reumatismo.2018.1070

  2515

  PDF: 1661
• 

  Emerging therapies for osteoporosis

  G. Minisola, A. Iuliano, I. Prevete

  112-124

  28-07-2014

  https://doi.org/10.4081/reumatismo.2014.784

  2080

  PDF: 1500
• 

  Duration of treatment for osteoporosis

  Luca Idolazzi, A. Fassio, D. Gatti, S. Tamanini, O. Viapiana, M. Rossini, S. Adami

  22-35

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.22

  3960

  PDF: 1341
• 

  Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran

  D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, M.S. Soleymani

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1540

  2069

  PDF: 1044

• PO:29:138 | Cetylated fatty acids and fibromyalgia: efficacy and tolerability in a prospective study Anna Capogna¹, Marco Bardelli¹, Luca Cantarini¹, Bruno Frediani¹ | ¹UOC Reumatologia, Dipartimento di Scienze mediche, chirurgiche e neuroscienze, Università degli Studi di Siena, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2200

  165
• 

  Comorbidity in polymyalgia rheumatica

  C. Chatzigeorgiou, S.L. Mackie

  35-43

  27-03-2018

  https://doi.org/10.4081/reumatismo.2018.1039

  4093

  PDF: 2270
• 

  Pain in rheumatoid arthritis: a critical review

  P. Sarzi-Puttini, F. Salaffi, M. Di Franco, L. Bazzichi, G. Cassisi, R. Casale, M. Cazzola, S. Stisi, M. Battellino, F. Atzeni

  18-27

  06-06-2014

  https://doi.org/10.4081/reumatismo.2014.760

  6809

  PDF: 3767
• 

  Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: a meta-analytic literature review

  A. Minelli, A. Vaona

  151-157

  19-07-2012

  https://doi.org/10.4081/reumatismo.2012.151

  2611

  PDF: 1564
• 

  Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

  L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

  224-232

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.748

  2606

  PDF: 1677
• 

  Intra-articular therapy with tumor necrosis factor-α antagonists: an update

  S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

  257-263

  14-03-2014

  https://doi.org/10.4081/reumatismo.2013.721

  2857

  PDF: 1386

• PO:02:016 | Real-world evidence of upadacitinib over two years in Italian patients with axial spondyloarthritis Mariagrazia Lorenzin¹, Giacomo Cozzi¹, Stefano Gentileschi², Michele Maria Luchetti Gentiloni³, Antonio Carletto⁴, Maria Sole Chimenti⁵, Maria Manara⁶, Luca Quartuccio⁷, Rosario Foti⁸, Salvatore D'Angelo⁹, Ariela Hoxha¹⁰, Carlo Selmi¹¹, Bernd Raffeiner¹², Alessandro Giollo¹, Alberto Cauli¹³, Carlo Salvarani¹⁴, Fabiola Atzeni¹⁵, Roberta Ramonda¹, Sir Study Group Spa E Psa Antonio Spadaro¹⁶. | ¹Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy; ²Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy; ³Clinica Medica, Ospedali Riuniti Ancona University Hospital, Ancona; Department of Clinical and Molecular Sciences, Ancona, Italy; ⁴Rheumatology Unit, Department of Medicine, AOUI University of Verona, Verona, Italy; ⁵Rheumatology, allergology and clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy; ⁶Humanitas San Pio X, Milano, Italy; ⁷University of Udine, Academic Hospital Santa Maria della Misericordia, Udine, Italy; ⁸Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Italy; ⁹Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy; ¹⁰Internal Medicine Unit, Thrombotic and Hemorrhagic Center, Department of Medicine-DIMED, University of Padua, Padova, Italy; ¹¹Department of Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ¹²Department of Rheumatology, Teaching Hospital of the Paracelsius Medical Hospital of Bolzano ASAA-SABES, Bolzano, Italy; ¹³Rheumatology Unit, Department of Medical Sciences, AOU and University of Cagliari, Monserrato, Cagliari, Italy; ¹⁴Department of Rheumatology, Azienda USL-IRCCS di Reggio Emilia and Università di Modena and Reggio Emilia, Reggio Emilia, Italy; ¹⁵Rheumatology Unit, University of Messina, Messina, Italy; ¹⁶Società Italiana di Reumatologia, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2007

  206
• 

  Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients

  F. Cacciapaglia, M.G. Anelli, D. Rizzo, E. Morelli, C. Scioscia, D. Mazzotta, F. Iannone, G. Lapadula

  97-102

  09-02-2016

  https://doi.org/10.4081/reumatismo.2015.829

  2569

  PDF: 1397
• 

  Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids

  S. Parisi, M. Bruzzone, C. Centanaro Di Vittorio, A. Laganà, C.L. Peroni, E. Fusaro

  286-291

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.691

  2963

  PDF: 1341
• 

  Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient

  C. Bruni, S. Bellando-Randone, L. Gargani, E. Picano, A. Pingitore, M. Matucci-Cerinic, S. Guiducci

  109-111

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.889

  2378

  PDF: 1333
• 

  Bradykinin and its role in osteoarthritis

  L. De Falco, A. Fioravanti, M. Galeazzi, S. Tenti

  97-104

  23-07-2013

  https://doi.org/10.4081/reumatismo.2013.97

  3566

  PDF: 2019
• 

  The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis

  A. Fassio, L. Idolazzi, M.A. Jaber, C. Dartizio, O. Viapiana, M. Rossini, D. Gatti

  65-71

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.878

  2311

  PDF: 1212

• CO:11:5 | Laboratory preliminary results from an open label, prospective, phase ii descriptive pilot trial of belimumab therapy for refractory and/or non criteria manifestations of antiphospholipid syndrome Alice Barinotti¹, Massimo Radin¹, Irene Cecchi¹, Beatrice Ala¹, Chiara Raymondi¹, Elena Rubini¹, Silvia G. Foddai¹, Lois Ira Maniulit Capulong¹, Alessio Conti¹, Alessandro Morotti¹, Dario Roccatello¹, Roberta Fenoglio¹, Savino Sciascia¹. | ¹Università di Torino, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1997

  201

• PO:28:126 | Effectiveness of the new AMEL system in the treatment of simple painful shoulder syndrome Antonietta Albanese¹, Emilio Battisti¹, Federico Filippi² | ¹Dipartimento SFTA, Università di Siena, Siena; ²Sanimed, Fisiomed, Vicenza, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2198

  209

• PO:05:069 | Risankizumab efficacy in peripheral and axial involvement: monocentric experience Roberta Foti¹, Ylenia Dal Bosco¹, Giorgio Amato¹, Elisa Visalli¹, Francesco De Lucia¹, Gabriella Paolí¹, Rosario Foti¹. | ¹UOSD Reumatologia AOU Policlinico G. Rodolico-S. Marco, Catania, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2012

  216

• CO:05:4 | Natural language processing reveals demographic features, comorbidities, and clinical domains to predict treatment longevity of b/tsDMARDs in psoriatic arthritis Antonio Tonutti^1|2, Pierandrea Morandini³, Cosimo Faeti³, Nicoletta Luciano^1|2, Saverio D'Amico³, Victor Savevski³, Carlo Selmi^1|2 | ¹Department of Biomedical Sciences, Humanitas University Pieve Emanuele, Milan, Italy; ²Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy; ³Artificial Intelligence Unit, IRCCS Humanitas Research Hospital Rozzano, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2275

  47
• 

  Guidelines on prevention and treatment of vitamin D deficiency

  S. Adami, E. Romagnoli, V. Carnevale, A. Scillitani, A. Giusti, M. Rossini, D. Gatti, R. Nuti, S. Minisola

  129-147

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.129

  11412

  PDF: 32988
• 

  Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

  N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

  93-102

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1235

  1241

  PDF: 806

• PO:13:188 | Menstrual alterations among women with rheumatoid arthritis: a comparative study across treatment modalities with focus on JAK inhibitors Angelica Napoletano¹, Francesca Arezzo², Marco Fornaro¹, Giuseppe Lopalco¹, Gennaro Cormio², Vincenzo Venerito¹, Florenzo Iannone¹. | ¹University of Bari, Rheumatology Unit Department of Precision and Regenerative Medicine, Jonica Area, Bari; ²Gynecologic Oncology, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2029

  396

• CO:02:2 | Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis: real world data from an Italian National Registry Valerio Fiorilli¹, Francesca Romana Spinelli¹, Florenzo Iannone², Chiara Bazzani³, Alberto Cauli⁴, Rosario Foti⁵, Marcello Govoni⁶, Francesco Paolo Cantatore⁷, Fabiola Atzeni⁸, Roberto Caporali⁹, Marco Sebastiani¹⁰, Roberta Ramonda¹¹, Serena Bugatti¹², Elisa Gremese¹³, Maria Sole Chimenti¹⁴, Bruno Frediani¹⁵, Maurizio Rossini¹⁶, Angelo Semeraro¹⁷, Leonardo Santo¹⁸, Gianfranco Ferraccioli¹⁹, Giovanni Lapadula²⁰, Fabrizio Conti¹. | ¹Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; ²Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica, Università degli Studi Aldo Moro, Bari; ³ASST Spedali Civili di Brescia, Unità di Reumatologia ed Immunologia Clinica, Brescia; ⁴Dipartimento di Scienze Mediche e Sanità Pubblica, Università degli Studi di Cagliari; ⁵A.O.U. Policlinico S. Marco, UOS Reumatologia, Catania; ⁶Dipartimento di Scienze Mediche, Università di Ferrara; ⁷Unità di Reumatologia,  Dipartimento di Medicina Specialistica, Università di Foggia; ⁸Dipartimento di Medicina Interna e Terapia Medica, UOC di Reumatologia, Università di Messina; ⁹Dipartimento di Scienze Cliniche e di Comunità, Università di Milano; ¹⁰Dipartimento di Medicina e Chirurgia, Università di Parma; ¹¹Unità di Reumatologia, Dipartimento di Medicina, Università di Padova; ¹²Dipartimento di Medicina Interna e Terapia Medica, Università di Pavia, ; ¹³IRCCS Istituto Clinico Humanitas, Dipartimento di Scienze Biomediche, Milano; ¹⁴Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma-Tor Vergata, ; ¹⁵Dipartimento di Medicina Clinica e Scienze Immunologiche, Università di Siena; ¹⁶Dipartimento di Medicina, Università di Verona; ¹⁷Presidio Ospedaliero Valle d'Itria, Unità Operativa di Reumatologia, Martina Franca; ¹⁸Presidio Ospedaliero "Mons. Dimiccoli", Unità Operativa Semplice di Reumatologia, Barletta; ¹⁹Gruppo Italiano di Studio sulla Early Arthritis, GISEA, Roma; ²⁰Gruppo Italiano di Studio sulla early Arthritis, GISEA, Bari, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1966

  222
• 

  Male osteoporosis

  A. Giusti, G. Bianchi

  136-143

  28-07-2014

  https://doi.org/10.4081/reumatismo.2014.786

  3035

  PDF: 1688
• 

  Management of cutaneous discomfort in patients with scleroderma: a clinical trial

  M. Muratore, L. Quarta, L. Raho, D. Costanza, S. Frisenda, F. Calcagnile, A. Grimaldi, E. Quarta, D. Carati, M. Guido, A. Zizza, G. Alessandrini

  240-247

  18-12-2013

  https://doi.org/10.4081/reumatismo.2013.240

  3829

  PDF: 1182

• CO:07:5 | Enhanced fibroblast signatures in females with early rheumatoid arthritis highlights a potential basis for poorer treatment outcomes Benedetta Monosi¹, James Perera², Alessandra Nerviani^2|3, Maria Sole Chimenti¹, Felice Rivellese^2|3, Costantino Pitzalis^2|3|4. | ¹Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; ²Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; ³Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research, London, UK; ⁴Department of Biomedical Sciences Humanitas University and IRCCS Humanitas Research Hospital, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1980

  206